Cagrilintide 5mg is a synthetic, long-acting peptide analogue of human amylin developed for research involving amylin-related signaling and receptor interactions. It is a modified 37-amino-acid peptide with structural features designed to distinguish it from naturally occurring amylin.
Cagrilintide has been characterized as an agonist of amylin receptors (AMYRs) and the calcitonin receptor (CTR). Its defined peptide structure makes it a compound of interest for controlled laboratory studies involving receptor binding, peptide characterization, molecular signaling, and related biochemical pathways.
Each vial contains 5mg of Cagrilintide and is supplied as a research material for laboratory and analytical applications.
Product Details
- Compound: Cagrilintide
- Research identifier: AM833
- Amount: 5mg
- Classification: Synthetic amylin analogue
- Peptide length: 37 amino acids
- Research targets: Amylin receptors (AMYRs) and calcitonin receptor (CTR)
- Form: Research peptide vial
- Intended use: Laboratory and analytical research
